Previous 10 | Next 10 |
SAN DIEGO, Aug. 25, 2020 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit was filed for certain investors NASDAQ: CODX shares. Investors, who purchased shares of Co-Diagnostics, Inc. (NASDAQ: CODX), have certain options and should contact the Shareholders Fou...
SALT LAKE CITY , Aug. 25, 2020 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that Company CEO Dwight Egan will be discussing the Company's signifi...
SALT LAKE CITY , Aug. 20, 2020 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that the United States Patent and Trademark Office has granted increased pat...
Co-Diagnostics Inc. (CODX) Q2 2020 Earnings Conference Call August 13, 2020 04:30 PM ET Company Participants Andrew Benson - IR Dwight H Egan - CEO Reed Benson - CFO Conference Call Participants Yi Chen - HC Wainwright Michael Okunewitch - Maxim Group Theodore O'Neill -...
Gainers: Midatech Pharma (NASDAQ: MTP ) +59% . More news on: Midatech Pharma plc, Mesoblast Limited, Sky Solar Holdings, Ltd., Stocks on the move, , Read more ...
Hexindai (NASDAQ: HX ) -41% . More news on: Hexindai Inc., Usio, Inc., Biofrontera AG, Stocks on the move, , Read more ...
Co-Diagnostics (NASDAQ: CODX) , a medical testing company that has risen sharply in both prominence and share price since the beginning of this year, fell hard in after-hours trading on Thursday. The culprit was the company's second-quarter results, which fell quite short of analyst expectati...
Co-Diagnostics (NASDAQ: CODX ) Q2 results : More news on: Co-Diagnostics, Inc., Healthcare stocks news, Stocks on the move, Earnings news and commentary, Read more ...
Co-Diagnostics (NASDAQ: CODX ) : Q2 GAAP EPS of $0.43 misses by $0.16 . More news on: Co-Diagnostics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
SALT LAKE CITY , Aug. 13, 2020 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today the filing of its operating results for the 3 month period ending ...
News, Short Squeeze, Breakout and More Instantly...
Co-Diagnostics, Inc. to Host Booth and Discuss Advancing POC/OTC Diagnostics at ADLM 2024 in Chicago PR Newswire SALT LAKE CITY , July 29, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company wi...
Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast PR Newswire SALT LAKE CITY , July 25, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the developme...
Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States PR Newswire SALT LAKE CITY , July 2, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx™"), a molecular diagnostics company w...